Peptide Therapeutics Market
Peptide Therapeutics Industry Report 2024, Featuring Profiles of 30+ Leading Players Including PeptiDream, PolyPeptide, Repligen, X-GEN Pharmaceuticals, Zydus Cadila and More
October 14, 2024 11:15 ET | Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Peptide...
22157.jpg
Lipid Nanoparticles Market Research 2024 - Global Forecast to 2029: Increasing Use of Lipid Nanoparticles in Anti-Cancer Research and Growing Demand for Advanced Drug Delivery Systems
October 07, 2024 11:52 ET | Research and Markets
Dublin, Oct. 07, 2024 (GLOBE NEWSWIRE) -- The "Lipid Nanoparticles Market by Product (Ionizable Lipids, Phospholipids, Kits, Reagents), LNP Type (SLNs, NLCs), Molecule (SiRNA, MRNA), Application,...
22157.jpg
Lipid Nanoparticles for Gene Therapy Market Research 2024: Gene Therapy Sales are Projected to Exceed $10bn by 2027 - LNPs have Gained Popularity as Carriers for Gene Therapies
September 18, 2024 09:05 ET | Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Gene therapy - Lipid nanoparticles" report has been added to ResearchAndMarkets.com's offering.This report discusses the developing trend and...
22157.jpg
Polymeric Nanoparticles Strategic Business Report 2023-2024 & 2030 - Growing Interest in Non-Toxic and Biodegradable Nanoparticles Bodes Well for Market Growth
September 17, 2024 07:44 ET | Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "Polymeric Nanoparticles - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Polymeric...
RNAZ White background cropped.jpg
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
September 17, 2024 07:00 ET | TransCode Therapeutics, Inc.
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
RNAZ White background cropped.jpg
TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10, 2024 07:00 ET | TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candi-date Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against
Polymer Nanocomposites Market
Polymer Nanocomposites Strategic Business Report 2024-2030: Revolutionizing Material Science with Nano-Innovations
September 06, 2024 07:27 ET | Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Polymer Nanocomposites - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Polymer...
RNAZ White background cropped.jpg
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05, 2024 07:00 ET | TransCode Therapeutics, Inc.
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
RNAZ White background cropped.jpg
TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
August 15, 2024 07:00 ET | TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
22157.jpg
Metal and Metal Oxide Nanoparticle Market Report 2024-2030, Featuring American Elements, Nanoshell, Meliorum Technologies, EPRUI Nanoparticles & Microspheres, NanoScale and Reinste Nanoventures
August 13, 2024 10:00 ET | Research and Markets
Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The "Metal and Metal Oxide Nanoparticle Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...